Gene: CYP2R1
Official Full Name: cytochrome P450 family 2 subfamily R member 1provided by HGNC
Gene Summary: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30344 | CYP2R1 Knockout cell line (HeLa) | Human | CYP2R1 | 1:3~1:6 | Negative | Online Inquiry |
KO30345 | CYP2R1 Knockout cell line (HCT 116) | Human | CYP2R1 | 1:2~1:4 | Negative | Online Inquiry |
KO30346 | CYP2R1 Knockout cell line (HEK293) | Human | CYP2R1 | 1:3~1:6 | Negative | Online Inquiry |
KO30347 | CYP2R1 Knockout cell line (A549) | Human | CYP2R1 | 1:3~1:4 | Negative | Online Inquiry |
CYP2R1 Gene Knockout Cell Lines are genetically modified cell lines designed to eliminate the expression of the CYP2R1 gene, a key player in vitamin D metabolism and signaling. By specifically knocking out this gene, researchers can investigate its biological role and the implications of vitamin D deficiency more effectively. These cell lines provide a crucial model for studying the downstream effects of CYP2R1 in various physiological and pathological contexts.
The primary function of CYP2R1 is to convert vitamin D to its active form, calcitriol, which in turn regulates calcium metabolism and bone health. The knockout of this gene allows scientists to explore various mechanisms related to calcium homeostasis, immune response, and overall vitamin D signaling pathways without the interference of the gene’s usual functions. This understanding is pivotal in uncovering the molecular underpinnings of diseases associated with vitamin D deficiency, such as osteoporosis, rickets, and certain autoimmune disorders.
In clinical and research settings, CYP2R1 Gene Knockout Cell Lines facilitate in-depth studies of vitamin D's role in cancer progression, metabolic disorders, and immune modulation. The insights gained from such research can lead to novel therapeutic strategies and diagnostic tools for addressing vitamin D-related health issues.
One of the significant advantages of these cell lines is their specificity and adaptability for various experimental designs, ranging from drug testing to gene therapy studies, unlike conventional cell lines that may have confounding genetic backgrounds. Moreover, their ease of use and reproducibility enhances experimental rigor and reliability.
For researchers and clinicians, the value of the CYP2R1 Gene Knockout Cell Lines cannot be overstated. They offer a powerful avenue for advancing our understanding of vitamin D biology and its implications in human health. Our company is dedicated to providing high-quality biological products and innovative solutions to empower researchers in their pursuit of scientific discovery. With our expert knowledge and commitment to excellence, we stand ready to support your research endeavors with our top-tier biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.